Filing Details
- Accession Number:
- 0001209191-11-057025
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2011-11-18 11:32:30
- Reporting Period:
- 2011-11-16
- Filing Date:
- 2011-11-18
- Accepted Time:
- 2011-11-18 11:32:30
- Original Submission Date:
- 2011-04-28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369786 | Sagent Pharmaceuticals Inc. | SGNT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1443476 | China Harvest Fund Ii, Lp | P.o. Box 309Gt Ugland House, South Church Street George Town, Grand Cayman E9 KY1-1104 | No | No | Yes | No | |
1518230 | Gp Ii Investment Capital Renaissance China | P.o. Box 309Gt Ugland House, South Church Street George Town, Grand Cayman E9 KY1-1104 | No | No | Yes | No | |
1518231 | China Renaissance Capital Investment Ii, L.p. | P.o. Box 309Gt Ugland House, South Church Street George Town, Grand Cayman E9 KY1-1104 | No | No | Yes | No | |
1518232 | Ltd Investments Gate Key | P.o. Box 146 Trident Chambers Road Town D8 TORTOLA | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-11-16 | 24,386 | $25.21 | 3,164,117 | No | 4 | S | Indirect | See note |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See note |
Footnotes
- These shares are owned directly by Key Gate Investments Limited, which is a wholly owned subsidiary of China Harvest Fund II, L.P., whose sole general partner is China Renaissance Capital Investment II, L.P., whose sole general partner is China Renaissance Investment II GP. China Harvest Fund II, L.P., China Renaissance Capital Investment II, L.P. and China Renaissance Investment II GP are indirect beneficial owners of the reported securities.